Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Pyridine, pyrimidine, quinoline, quinazoline, and naphthalene urotensin-II receptor antagonists

Pyridine, pyrimidine, quinoline, quinazoline, and naphthalene urotensin-II receptor antagonists

US Patent 7320989 · Granted Jan 22, 2008

Estimated economic value: $1,205,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

SGLT2/DPP4 inhibitor and application thereof2025
Spiro compound serving as ERK inhibitor, and application thereof2025
SGLTS/DPP4 inhibitor and application thereof2025
Context-aware observational entity recognition and capture2025
BRD4 inhibitor compound in solid form and preparation method therefor and use th2025
Glucoside derivative that acts as SGLT1 inhibitor and application thereof2025
Cyclic dinucleotide analogue, pharmaceutical composition thereof, and applicatio2024
Macrocyclic derivatives acting as XIa factor inhibitor2024
Functions for path traversals from seed input to output2024
Systems and methods for creating a data layer based on content from data sources2024
Diarylthiohydantoin compound as androgen receptor antagonist2024
Heterocyclic compound2023